Above Food Ingredients Inc. (ABVEW) Analyse boursière

Présentation de l'entreprise

Above Food Ingredients Inc. (ABVEW) operates as a regenerative ingredient company that maintains a vertically integrated supply chain across multiple international jurisdictions, including Canada, the United States, Mexico, China, France, Turkey, and other global markets. The company structures its operations through two distinct segments identified as Disruptive Agriculture and Rudimentary Ingredients, alongside a Consumer segment, though specific sector and industry classifications are not disclosed in the available data. The firm generates an annual revenue of 294.84 millions of dollars based on trailing twelve-month figures, while the total number of employees and the specific market capitalization are currently not reported in the provided financial records. The absence of disclosed market cap and employee count metrics limits the immediate ability to gauge the absolute scale of operations relative to peers, yet the reported revenue of 294.84 millions suggests a significant operational footprint despite the negative financial performance indicators present in other metrics.

Santé financière

The company reported a revenue of 294.84 millions of dollars over the trailing twelve months, yet this top-line figure masks a net income loss of 61.29 millions of dollars and an EBITDA deficit of 40.34 millions of dollars. The substantial gap between the 294.84 millions in revenue and the negative 61.29 millions in net income reveals a cost structure where expenses, including cost of goods sold and operating expenditures, significantly exceed total sales, resulting in a profit margin of -23.4%. While free cash flow figures are not available in the current dataset, the reported cash balance stands at 664.43 thousands of dollars, indicating limited immediate liquidity reserves against operational obligations. The gross margin is recorded at -2.8%, the operating margin at -23.3%, and the profit margin at -23.4%, all of which indicate that the company is currently generating losses on nearly every dollar of sales before interest and taxes, as well as on its overall operational activities. When comparing total cash holdings of 664.43 thousands of dollars against total debt obligations of 133.84 millions of dollars, the balance sheet appears highly leveraged, a position further quantified by a debt-to-equity ratio that is not explicitly calculated but implied by the disparity between assets and liabilities. Additionally, the current ratio is listed at 0.23, which indicates that the company's current assets are insufficient to cover its current liabilities, signaling potential short-term liquidity constraints. Finally, return on equity and return on assets metrics are not available, preventing a direct assessment of management effectiveness in generating returns on the capital base or total assets at this time.

Évaluation de la valorisation

Trailing twelve-month P/E and forward P/E ratios are both unavailable due to the negative earnings position, which precludes the calculation of these traditional valuation multiples and implies that earnings-based valuation models are not applicable in their standard form. The price-to-book ratio is reported at -0.49, a negative figure that indicates the market values the company's equity below its book value, suggesting a market premium is negative or that the asset base is undervalued or impaired relative to market price. Alternative valuation metrics such as the price-to-sales ratio and EV/EBITDA are not disclosed in the available facts, limiting the ability to assess the company's valuation relative to its sales volume or enterprise value earnings. The stock has traded with a 52-week high of 0.31 dollars and a 52-week low of 0.21 dollars, placing the current trading price within this historical range but requiring specific price data to calculate the exact percentage distance from the high or low. The beta value is recorded at 0.13, which suggests that the stock price exhibits low volatility relative to the broader market, moving significantly less than the overall market index during periods of price fluctuation.

Growth & Income

Revenue growth year-over-year stands at -45.0%, while earnings growth year-over-year is not available, indicating a sharp contraction in top-line sales without a corresponding earnings figure to compare growth rates. The absence of a positive earnings growth rate alongside the -45.0% revenue decline implies that the company is struggling to maintain profitability as sales volumes decrease, rather than growing faster than revenue. As a non-dividend payer, the company does not distribute a dividend yield or utilize a payout ratio, meaning that all available cash flows are theoretically available for reinvestment or debt servicing rather than shareholder distributions. The overall growth and income profile is characterized by significant revenue contraction of -45.0% and a lack of dividend income, reflecting a company currently focused on survival and operational restructuring rather than organic growth or income generation for shareholders.